Cancer immunotherapy: harnessing the immune system to battle cancer

被引：1058

作者：

Yang, Yiping ^{[1
,2
]}

机构：

[1] Duke Univ, Dept Med, Div Hematol Malignancies & Cellular Therapy, Durham, NC 27710 USA

[2] Duke Univ, Dept Immunol, Durham, NC 27710 USA

来源：

JOURNAL OF CLINICAL INVESTIGATION | 2015年 / 125卷 / 09期

关键词：

B7; FAMILY; T-CELLS; CTLA-4; MEMBER; IMMUNOGLOBULIN; ACTIVATION; ANTIBODY; SUPERFAMILY; LYMPHOCYTES; RECEPTOR;

D O I：

10.1172/JCI83871

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

The recent clinical successes of immune checkpoint blockade and chimeric antigen receptor T cell therapies represent a turning point in cancer immunotherapy. These successes also underscore the importance of understanding basic tumor immunology for successful clinical translation in treating patients with cancer. The Reviews in this Review Series focus on current developments in cancer immunotherapy, highlight recent advances in our understanding of basic aspects of tumor immunology, and suggest how these insights can lead to the development of new immunotherapeutic strategies.

引用

页码：3335 / 3337

页数：3

共 32 条

[1] Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].

Brahmer, Julie R. ;

Tykodi, Scott S. ;

Chow, Laura Q. M. ;

Hwu, Wen-Jen ;

Topalian, Suzanne L. ;

Hwu, Patrick ;

Drake, Charles G. ;

Camacho, Luis H. ;

Kauh, John ;

Odunsi, Kunle ;

Pitot, Henry C. ;

Hamid, Omid ;

Bhatia, Shailender ;

Martins, Renato ;

Eaton, Keith ;

Chen, Shuming ;

Salay, Theresa M. ;

Alaparthy, Suresh ;

Grosso, Joseph F. ;

Korman, Alan J. ;

Parker, Susan M. ;

Agrawal, Shruti ;

Goldberg, Stacie M. ;

Pardoll, Drew M. ;

Gupta, Ashok ;

Wigginton, Jon M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465

[2] CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia [J].

Brentjens, Renier J. ;

Davila, Marco L. ;

Riviere, Isabelle ;

Park, Jae ;

Wang, Xiuyan ;

Cowell, Lindsay G. ;

Bartido, Shirley ;

Stefanski, Jolanta ;

Taylor, Clare ;

Olszewska, Malgorzata ;

Borquez-Ojeda, Oriana ;

Qu, Jinrong ;

Wasielewska, Teresa ;

He, Qing ;

Bernal, Yvette ;

Rijo, Ivelise V. ;

Hedvat, Cyrus ;

Kobos, Rachel ;

Curran, Kevin ;

Steinherz, Peter ;

Jurcic, Joseph ;

Rosenblat, Todd ;

Maslak, Peter ;

Frattini, Mark ;

Sadelain, Michel .

SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (177)

[3] Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15 [J].

Brentjens, RJ ;

Latouche, JB ;

Santos, E ;

Marti, F ;

Gong, MC ;

Lyddane, C ;

King, PD ;

Larson, S ;

Weiss, M ;

Rivière, I ;

Sadelain, M .

NATURE MEDICINE, 2003, 9 (03) :279-286

[4] A NEW MEMBER OF THE IMMUNOGLOBULIN SUPERFAMILY - CTLA-4 [J].

BRUNET, JF ;

DENIZOT, F ;

LUCIANI, MF ;

ROUXDOSSETO, M ;

SUZAN, M ;

MATTEI, MG ;

GOLSTEIN, P .

NATURE, 1987, 328 (6127) :267-270

[5] Cytotoxic T lymphocyte antigen-4 and immune checkpoint blockade [J].

Buchbinder, Elizabeth ;

Hodi, F. Stephen .

JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (09) :3377-3383

[6] Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future [J].

Chen, Lieping ;

Han, Xue .

JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (09) :3384-3391

[7] Cancer Immunotherapy [J].

Couzin-Frankel, Jennifer .

SCIENCE, 2013, 342 (6165) :1432-1433

[8]

Dong HD, 1999, NAT MED, V5, P1365

[9]

Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730

[10] Mechanisms of immune evasion by tumors [J].

Drake, CG ;

Jaffee, E ;

Pardoll, DM .

ADVANCES IN IMMUNOLOGY, VOL 90: CANCER IMMUNOTHERAPY, 2006, 90 :51-81

← 1 2 3 4 →